CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,553,000 | +88.2% | 2,239,300 | +123.9% | 4.54% | +89.8% |
| Q3 2021 | $2,950,000 | -49.0% | 1,000,000 | -56.8% | 2.39% | -39.7% |
| Q2 2021 | $5,786,000 | -20.9% | 2,314,533 | -8.0% | 3.96% | -16.6% |
| Q1 2021 | $7,318,000 | -39.4% | 2,514,647 | -32.9% | 4.75% | -36.8% |
| Q4 2020 | $12,075,000 | +30.2% | 3,749,890 | -13.1% | 7.53% | -13.9% |
| Q3 2020 | $9,274,000 | +1189.8% | 4,313,617 | +596.4% | 8.74% | +1052.0% |
| Q2 2020 | $719,000 | +26.8% | 619,460 | +0.4% | 0.76% | +22.4% |
| Q1 2020 | $567,000 | +10.3% | 616,695 | +89.4% | 0.62% | +25.0% |
| Q4 2019 | $514,000 | +89.0% | 325,610 | +0.1% | 0.50% | +61.6% |
| Q3 2019 | $272,000 | -2.5% | 325,185 | +0.2% | 0.31% | -3.2% |
| Q2 2019 | $279,000 | -10.9% | 324,452 | +0.4% | 0.32% | +9.3% |
| Q1 2019 | $313,000 | +244.0% | 323,026 | +160.6% | 0.29% | +163.6% |
| Q4 2018 | $91,000 | -78.7% | 123,941 | -37.2% | 0.11% | -72.2% |
| Q3 2018 | $427,000 | – | 197,459 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|